Kyle Esplin

Former Chair, Scottish Hemp Association

Kyle Esplin, team member at Precision Plants

About Kyle

International health innovator and hemp advocate. Personal recovery journey using CBD sparked passion for the hemp industry, featured on Sky News, BBC News, and VICE News. Producer of documentary 'Hemp: Eat Build Heal', bringing hemp's transformative potential to mainstream audiences.

Role at Precision Plants

Kyle advises on genetics and landrace conservation, protecting native hemp varieties worldwide. As Landrace Warden, he ensures Precision Plants' CRISPR work preserves genetic diversity while creating commercially viable varieties. His genetics consultancy experience guides variety selection and breeding strategies.

Hemp & Genetics Expertise

Landrace Warden - protecting native hemp varieties worldwide
Chair, Scottish Hemp Association (2020-2023)
Documentary producer: 'Hemp: Eat Build Heal'
Award-winning CBD product designer and genetics consultant

Media Features

Featured on Sky News, BBC News, and VICE News discussing hemp advocacy and personal recovery journey using CBD. Produced documentary 'Hemp: Eat Build Heal' to educate audiences on hemp's transformative applications across nutrition, construction, and wellness.

Hemp: Eat Build Heal

Kyle produced this groundbreaking documentary exploring hemp's diverse applications across health, nutrition, and construction. The film showcases the incredible versatility of hemp and its potential to transform multiple industries.

Documentary by Kyle Esplin

Aerial view of thriving UK hemp field at sunset - Precision Plants sustainable agriculture

Ready to Grow the Future of
British Agriculture?

"There is only one known annually renewable natural resource… capable of providing the majority of the world's paper and textiles… energy needs, while simultaneously reducing pollution… and that substance is… Cannabis hemp."
Jack Herer, legendary hemp advocate and author of The Emperor Wears No ClothesJack Herer, Emperor of Hemp

Join our farm trial programme or register your interest for our 2032 commercial seed release.